MedPath

Effect of ondansetron alone on brain contusio

Phase 3
Conditions
Minor head trauma.
Registration Number
IRCT20191127045526N1
Lead Sponsor
Zahedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
64
Inclusion Criteria

Head trauma with GCS>14
Head trauma with vomiting

Exclusion Criteria

Patients with shock signes
patients with gastrointestinal disease causing nausea

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ausa vomiting treatment. Timepoint: 15 30 60 minutes after drug injection. Method of measurement: Patient evaluation in times15 30 60 minutes after drug.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath